Get the Stockscreener App
0.4125
1.17%
-0.0049
Pre-market:
.40
-0.0125
-3.03%
Incannex Healthcare Inc stock is traded at $0.4125, with a volume of 17.01M.
It is down -1.17% in the last 24 hours and up +13.89% over the past month.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
See More
Previous Close:
$0.4174
Open:
$0.4031
24h Volume:
17.01M
Relative Volume:
0.62
Market Cap:
$142.82M
Revenue:
-
Net Income/Loss:
$-21.91M
P/E Ratio:
-0.2768
EPS:
-1.49
Net Cash Flow:
-
1W Performance:
-7.70%
1M Performance:
+13.89%
6M Performance:
+94.58%
1Y Performance:
-75.15%
1-Day Range:
$0.38
$0.4181
1-Week Range:
$0.38
$0.497
52-Week Range:
$0.08
$2.25
Incannex Healthcare Inc Stock (IXHL) Company Profile
Name
Incannex Healthcare Inc
Sector
Phone
61 409 840 786
Address
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.4125 | 144.51M | 0 | -21.91M | 0 | -1.49 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Incannex Healthcare Inc Stock (IXHL) Latest News
Penny Stocks To Keep An Eye OnDecember 3rd - MarketBeat
Is Incannex Healthcare Inc. (IQI0) stock a top hedge fund pickPortfolio Return Summary & Accurate Entry/Exit Alerts - Newser
Is Incannex Healthcare Inc. (IQI0) stock attractive post correctionTrend Reversal & Safe Entry Momentum Tips - Newser
What drives Incannex Healthcare Inc stock priceMomentum Stock Picks & Small Budget Trading Ideas - earlytimes.in
Does Incannex Healthcare Inc. stock trade at a discount to peers2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Does Incannex Healthcare Inc. (IQI0) stock trade below intrinsic valueWeekly Stock Report & High Accuracy Trade Alerts - Newser
FDA grants fast track designation to Incannex’s OSA treatment By Investing.com - Investing.com South Africa
Incannex Healthcare Stock Soars 15% After FDA Fast Tracks Obstructive Sleep Apnea Drug - Stocktwits
Incannex Healthcare (IXHL) Stock Earns FDA Fast Track Designation for Groundbreaking OSA Drug IHL-42X - parameter.io
Incannex granted Fast Track designation for IHL-42X in OSA - TipRanks
Incannex Healthcare's Obstructive Sleep Apnea Drug Candidate Granted Fast Track Designation - marketscreener.com
Incannex Healthcare stock soars after FDA grants Fast Track status for OSA drug - Investing.com Australia
Incannex granted FDA fast track designation for IHL-42X in obstructive sleep apnea - marketscreener.com
Incannex Healthcare Gains FDA Fast Track for IHL-42X - TipRanks
Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA) - The Manila Times
Incannex Healthcare Inc Granted FDA Fast Track for IHL-42X - TradingView
Why global investors buy Incannex Healthcare Inc. (IQI0) stockJuly 2025 Market Mood & Low Drawdown Momentum Ideas - Newser
Is Incannex Healthcare Inc. (IQI0) stock protected from inflationBreakout Watch & Comprehensive Market Scan Reports - Newser
Is Incannex Healthcare Inc. (IQI0) stock overpriced at current multiplesTrade Entry Report & Weekly Setup with ROI Potential - Newser
Why Incannex Healthcare Inc. stock appeals to dividend seekersJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
Incannex Healthcare (IXHL) Stock Analysis Report | Financials & Insights - Benzinga
What Makes Incannex Healthcare Inc. (IXHL) a New Buy Stock - sharewise.com
Incannex Healthcare (NASDAQ:IXHL) Trading Up 1.1%Still a Buy? - MarketBeat
Will Incannex Healthcare Inc. stock outperform growth indexes2025 Market Trends & Reliable Intraday Trade Alerts - BỘ NỘI VỤ
Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus - ADVFN
Incannex Shares Surge Following Promising Sleep Apnea Trial Data - MSN
Would You Still Hold Incannex Healthcare Stock If It Fell Another 30%? - Trefis
How Incannex Healthcare Inc. (IQI0) stock reacts to fiscal policies2025 Price Momentum & Expert Approved Trade Ideas - newser.com
Incannex Healthcare (NASDAQ: IXHL) Phase 2 OSA Data Show 83% AHI Drop, 57.6% Report Gains - Stock Titan
Is Incannex Healthcare Inc. (IQI0) stock a buy during volatile marketsWeekly Stock Recap & Weekly High Momentum Picks - newser.com
Is Incannex Healthcare Inc. (IQI0) stock worth holding before Fed meeting2025 Short Interest & Capital Efficiency Focused Ideas - newser.com
How higher bond yields impact Incannex Healthcare Inc. (IQI0) stockWeekly Gains Report & Smart Swing Trading Techniques - newser.com
MSN Money - MSN
Has Incannex Healthcare Inc. formed a bullish divergencePortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
What valuation multiples suggest for Incannex Healthcare Inc. stockWeekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Can Incannex Healthcare Inc. recover in the next quarterEarnings Recap Summary & Growth-Oriented Investment Plans - newser.com
What earnings margins imply for Incannex Healthcare Inc. (IQI0) stockMarket Movers & Accurate Intraday Trade Tips - newser.com
Incannex Healthcare Inc Stock (IXHL) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.87%
4.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):